Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-blind, Controlled Clinical Trial on the Antiseptic Efficacy and Tolerability of Lavasept® 0.04% on Acute Traumatic Wounds

NCT01153620 is registered in ClinicalTrials.gov with B. Braun Ltd. Centre of Excellence Infection Control as lead sponsor.

NCT NCT01153620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01153620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-blind, Controlled Clinical Trial on the Antiseptic Efficacy and Tolerability of Lavasept® 0.04% on Acute Traumatic Wounds
Lead sponsor
B. Braun Ltd. Centre of Excellence Infection Control
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2010
Completion date
January 31, 2011
Enrollment
61 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

wounds